- Home
- ALIS vs SXTC Comparison
ALIS vs SXTC Comparison
Compare ALIS & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$0.06
Company Overview
Basic Information| Metric | ALIS | SXTC |
|---|---|---|
| Founded | 2024 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 92.9M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALIS | SXTC |
|---|---|---|
| Price | $10.17 | $0.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 41.9K | ★ 31.9M |
| Earning Date | 01-01-0001 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.87 | $0.03 |
| 52 Week High | $10.25 | $6.98 |
Technical Indicators
Market Signals| Indicator | ALIS | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 53.98 | 21.28 |
| Support Level | $10.05 | $0.03 |
| Resistance Level | $10.17 | $1.71 |
| Average True Range (ATR) | 0.03 | 0.20 |
| MACD | -0.00 | -0.25 |
| Stochastic Oscillator | 21.00 | 0.67 |
Price Performance
Historical Comparison ALIS
SXTC
About ALIS Calisa Acquisition Corp Ordinary shares
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.